Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · May 17, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to improve how we test and treat people for HIV in Mobile County, Alabama. Researchers are looking at a new approach that combines different strategies to help more people get tested for HIV, connect them quickly to medical care after a positive result, and start them on treatment right away. The goal is to make sure that those who need help receive it as soon as possible, which can lead to better health outcomes.
To participate in the trial, you need to be at least 18 years old and work in a role related to HIV care, like a nurse, doctor, or outreach worker at local health facilities. If you're under 18, you can still participate if you’ve tested for HIV in the area since the program started. Participants can expect to be part of a team effort to improve HIV services and may help shape how care is provided in their community. It’s important to know that everyone involved must agree to take part in the study by providing informed consent.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * AIM 1 \& 3:
- * Fit into one of the following categories:
- • 1) MCHD leadership, 2) ADPH leadership, 3) clinic administrators, 4) outreach testing specialists, 5) linkage coordinators and community health workers, 6) physicians, 7) nurses, 8) counselors all working at HIV care facilities in the six MCHD jurisdiction counties.
- • Over the age of 18 years old.
- • AIM 2: (IDIs)
- • Over the age of 13 years old
- • Tested for HIV in MCHD jurisdiction from time of COASTAL implementation to 36 months post-implementation start date.
- Exclusion Criteria:
- • Exclusion criteria include unwillingness or inability to provide informed consent.
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials